Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
post
Last Updated on: 18 December, 2024
Author: Getaka|Social: Getaka Financial Technology X (Earlier Twitter) Profile Getaka Financial Technology LinkedIn Logo
Stock Ticker - BSE: 542919 | NSE: ARTEMISMED

Artemis Medicare Services Ltd: Share Price Intrinsic Value and Fundamental Analysis

Share Price and Basic Stock Data

Last Updated: December 17, 2024, 10:16 pm

Market Cap 4,511 Cr.
Current Price 327
High / Low 348/141
Stock P/E69.5
Book Value 57.9
Dividend Yield0.14 %
ROCE13.6 %
ROE11.4 %
Face Value 1.00
PEG Ratio3.73

Stock P/E, Current Price, and Intrinsic Value Over Time

View Share Price Target for Artemis Medicare Services Ltd

Competitors of Artemis Medicare Services Ltd

Stock NameMarket CapCurrent PriceHigh / LowStock P/EBook ValueDividend YieldROCEROEFace Value
NG Industries Ltd 58.1 Cr. 173 230/1369.95 1242.02 %6.50 %5.63 % 10.0
Global Longlife Hospital and Research Ltd 33.6 Cr. 32.0 61.7/27.0 25.90.00 %2.51 %4.72 % 10.0
Gian Lifecare Ltd 19.6 Cr. 19.0 29.0/17.04.81 19.20.00 %29.2 %24.6 % 10.0
Fortis Malar Hospitals Ltd 115 Cr. 61.4 108/44.0 15.969.2 %3.29 %9.12 % 10.0
Family Care Hospitals Ltd 37.4 Cr. 6.93 10.3/6.230.91 2.670.00 %15.4 %24.1 % 10.0
Industry Average25,723.20 Cr783.7754.7889.623.07%12.34%12.42%9.12

All Competitor Stocks of Artemis Medicare Services Ltd

Quarterly Result

MonthMar 2021Jun 2021Sep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
Sales127120136142146163182181187201217210217
Expenses107108117124129144158156163174184179181
Operating Profit20132018171924262527333236
OPM %16%11%14%13%12%12%13%14%13%14%15%15%17%
Other Income5111121121222
Interest2223445556788
Depreciation555566788991010
Profit before tax177131081114141413191619
Tax %26%39%36%36%-57%22%31%23%23%26%27%29%28%
Net Profit1348713910111010141214
EPS in Rs0.970.310.630.511.010.650.730.800.780.731.010.851.02

Last Updated: Unknown

Quarterly Chart

Profit & Loss - Annual Report

Last Updated: Unknown

MonthMar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024
Sales217261368402459503547563402545714845
Expenses194234325359406442480501367477620717
Operating Profit2327434353606662356894128
OPM %10%11%12%11%11%12%12%11%9%12%13%15%
Other Income213543247377
Interest151312999111312111930
Depreciation9912121518202221212938
Profit before tax072127323537329395368
Tax %0%0%12%21%16%24%44%36%20%16%25%28%
Net Profit071922272721207334049
EPS in Rs0.020.320.881.031.291.270.981.540.542.462.963.62
Dividend Payout %0%0%0%0%0%0%0%0%0%0%15%12%

Profit & Loss Yearly Chart

YoY Net Profit Growth

Year2014-20152015-20162016-20172017-20182018-20192019-20202020-20212021-20222022-20232023-2024
YoY Net Profit Growth (%)171.43%15.79%22.73%0.00%-22.22%-4.76%-65.00%371.43%21.21%22.50%
Change in YoY Net Profit Growth (%)0.00%-155.64%6.94%-22.73%-22.22%17.46%-60.24%436.43%-350.22%1.29%

Artemis Medicare Services Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 10 years from 2014-2015 to 2023-2024.

Growth

Compounded Sales Growth
10 Years:12%
5 Years:9%
3 Years:28%
TTM:12%
Compounded Profit Growth
10 Years:22%
5 Years:18%
3 Years:98%
TTM:45%
Stock Price CAGR
10 Years:%
5 Years:%
3 Years:103%
1 Year:83%
Return on Equity
10 Years:10%
5 Years:8%
3 Years:10%
Last Year:11%

Last Updated: Unknown

Balance Sheet

Last Updated: December 14, 2024, 3:59 pm

MonthMar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Sep 2024
Equity Capital2121212121210.00131313131414
Reserves109116135163183210280301308348393438783
Borrowings11811085689491114108137190268305307
Other Liabilities39669093124130160159130145207191215
Total Liabilities2873133313454224525555815896978829481,318
Fixed Assets237236239249283309381387372476584699718
CWIP0001274349568164953344
Investments0000000246121515
Other Assets50779194112100124137132152192200541
Total Assets2873133313454224525555815896978829481,318

Reserves and Borrowings Chart

Cash Flow

MonthMar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024
Cash from Operating Activity +22455320587241562761129108
Cash from Investing Activity +-5-12-10-14-74-67-50-22-34-106-153-89
Cash from Financing Activity +-18-21-35-2419-1014-33134430-27
Net Cash Flow-1117-183-4526-27-8

Free Cash Flow

MonthMar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024
Free Cash Flow-95.00-83.00-42.00-25.00-41.00-31.00-48.00-46.00-102.00-122.00-174.00-177.00

Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)

Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.

Free Cash Flow Chart

Financial Efficiency Indicators

MonthMar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024
Debtor Days404139494840525048474336
Inventory Days2626262119
Days Payable144237195189187
Cash Conversion Cycle-78-171-129-120-12040525048474336
Working Capital Days-9-70-59-31-44-53-26-28-15-10-29-17
ROCE %6%8%14%15%16%15%14%11%4%10%11%14%

Financial Efficiency Indicators Chart

Share Holding Pattern

MonthSep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024
Promoters69.82%69.82%69.82%69.59%69.27%68.91%68.91%68.03%68.03%68.03%68.03%67.51%
FIIs0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.07%0.09%0.11%0.10%0.16%
DIIs1.22%1.22%1.10%0.91%0.90%1.15%1.37%1.41%1.51%1.96%2.61%3.45%
Government7.37%7.37%7.37%7.34%7.31%7.27%7.27%7.18%7.18%7.18%7.18%7.12%
Public21.59%21.59%21.71%22.17%22.53%22.65%22.43%23.30%23.18%22.72%22.08%21.76%
No. of Shareholders10,76512,82712,09815,17714,63717,99518,10019,08220,52922,37519,99319,795

Shareholding Pattern Chart

No. of Shareholders

Mutual Fund Holdings

Fund NameNo of SharesAUM (%)Amount Invested (Cr)Previous Number of SharesPrevious DatePercentage Change
Bandhan Small Cap Fund421,0790.157.6879,3262024-12-17430.82%
LIC MF Focused Fund205,2022.833.7479,3262024-12-17158.68%
LIC MF Healthcare Fund156,1724.582.8579,3262024-12-1796.87%
LIC MF Small Cap Fund122,70112.2479,3262024-12-1754.68%
LIC MF Dividend Yield Fund79,3260.951.4579,3262024-12-170%
LIC MF Value Fund76,3931.271.3979,3262024-12-17-3.7%
Bandhan Midcap Fund70,0160.111.2879,3262024-12-17-11.74%
LIC MF Equity Savings Fund3,8880.450.0779,3262024-12-17-95.1%
Motilal Oswal S&P BSE Healthcare ETF4070.060.0179,3262024-12-17-99.49%

ROCE Trend

EPS Trend

Key Financial Ratios

MonthMar 24Mar 23Mar 22Mar 21Mar 20
FaceValue1.001.001.0010.0010.00
Basic EPS (Rs.)3.622.892.404.9014.95
Diluted EPS (Rs.)3.532.792.294.9014.95
Cash EPS (Rs.)6.585.154.0520.9131.80
Book Value[Excl.RevalReserv]/Share (Rs.)28.4625.3722.23243.05236.99
Book Value[Incl.RevalReserv]/Share (Rs.)33.4730.4027.29243.05236.99
Revenue From Operations / Share (Rs.)64.6754.9841.91308.51426.82
PBDIT / Share (Rs.)10.317.555.3929.2649.90
PBIT / Share (Rs.)7.345.243.7113.0132.81
PBT / Share (Rs.)5.043.772.815.6923.14
Net Profit / Share (Rs.)3.622.832.374.6514.70
NP After MI And SOA / Share (Rs.)3.622.882.404.9014.95
PBDIT Margin (%)15.9413.7312.869.4811.69
PBIT Margin (%)11.359.538.864.217.68
PBT Margin (%)7.796.866.701.845.42
Net Profit Margin (%)5.595.155.651.503.44
NP After MI And SOA Margin (%)5.595.235.731.583.50
Return on Networth / Equity (%)12.9111.4910.872.026.31
Return on Capital Employeed (%)12.6710.058.603.5710.13
Return On Assets (%)5.054.264.481.083.37
Long Term Debt / Equity (X)0.590.630.550.330.20
Total Debt / Equity (X)0.660.710.620.330.24
Asset Turnover Ratio (%)0.930.890.830.680.99
Current Ratio (X)0.970.820.910.920.74
Quick Ratio (X)0.920.750.820.840.67
Dividend Payout Ratio (NP) (%)12.440.000.000.000.00
Dividend Payout Ratio (CP) (%)6.830.000.000.000.00
Earning Retention Ratio (%)87.560.000.000.000.00
Cash Earning Retention Ratio (%)93.170.000.000.000.00
Interest Coverage Ratio (X)4.485.155.963.005.16
Interest Coverage Ratio (Post Tax) (X)2.572.933.621.232.52
Enterprise Value (Cr.)2505.471107.95765.31372.04243.97
EV / Net Operating Revenue (X)2.851.501.380.910.43
EV / EBITDA (X)17.8910.9410.739.603.69
MarketCap / Net Operating Revenue (X)2.631.241.100.710.32
Retention Ratios (%)87.550.000.000.000.00
Price / BV (X)6.062.722.080.910.58
Price / Net Operating Revenue (X)2.631.241.100.710.32
EarningsYield0.020.040.050.020.10

Profitability Ratios (%)

Liquidity Ratios

Liquidity Ratios (%)

Interest Coverage Ratios (%)

Valuation Ratios

Fair Value

Fair Value of Artemis Medicare Services Ltd as of December 18, 2024 is: 459.38

Calculation basis:

  • Fair value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100)
  • P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
  • Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
  • Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
  • Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.

This formula allows us to gauge the fair value of the stock by analyzing its fundamental indicators.

As of December 18, 2024, Artemis Medicare Services Ltd is Undervalued by 40.48% compared to the current share price 327.00

Intrinsic Value of Artemis Medicare Services Ltd as of December 18, 2024 is: 545.02

Calculation basis:

  • Intrinsic value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100) * (1 + EPS CAGR for Last 5 Years)
  • P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
  • Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
  • Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
  • Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.
  • EPS CAGR (Compound Annual Growth Rate): Represents the geometric mean growth rate of earnings per share over the last 5 years. It provides insight into the historical growth trajectory of the company's earnings.

This formula allows us to gauge the intrinsic value of the stock by analyzing its fundamental indicators along with EPS growth.

As of December 18, 2024, Artemis Medicare Services Ltd is Undervalued by 66.67% compared to the current share price 327.00

Last 5 Year EPS CAGR: 18.64%

*Investments are subject to market risks

Strength and Weakness

StrengthWeakness
  1. The stock has a low average Working Capital Days of -32.58, which is a positive sign.
  2. The stock has a low average Cash Conversion Cycle of -25.17, which is a positive sign.
  3. The company has higher reserves (289.77 cr) compared to borrowings (153.46 cr), indicating strong financial stability.
  4. The company has shown consistent growth in sales (485.50 cr) and profit (30.00 cr) over the years.
  1. The stock has a low average ROCE of 11.50%, which may not be favorable.

Stock Analysis

  • Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Artemis Medicare Services Ltd:
    1. Net Profit Margin: 5.59%
      • Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
    2. ROCE: 12.67% (Industry Average ROCE: 12.34%)
      • ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
    3. ROE%: 12.91% (Industry Average ROE: 11.92%)
      • ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
    4. Interest Coverage Ratio (Post Tax): 2.57
      • Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
    5. Quick Ratio: 0.92
      • Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
    6. Stock P/E: 69.5 (Industry average Stock P/E: 43.82)
      • Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
    7. Total Debt / Equity: 0.66
      • Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
    The current analysis is available for review. It's important to conduct thorough research and consider consulting with financial professionals before making any investment decisions.
    Stock Rating:

About the Company - Qualitative Analysis

Artemis Medicare Services Ltd. is a Public Limited Listed company incorporated on 18/05/2004 and has its registered office in the State of Delhi, India. Company’s Corporate Identification Number(CIN) is L85110DL2004PLC126414 and registration number is 126414. Currently Company is involved in the business activities of Hospital activities. Company’s Total Operating Revenue is Rs. 544.78 Cr. and Equity Capital is Rs. 13.24 Cr. for the Year ended 31/03/2022.
INDUSTRYADDRESSCONTACT
Hospitals & Medical ServicesPlot No. 14, Delhi Delhi 110075investor@artemishospitals.com
http://www.artemishospitals.com
Management
NamePosition Held
Mr. Onkar KanwarChairman & Non-Exe.Director
Dr.(Mrs.) Devlina ChakravartyManaging Director
Mr. Neeraj KanwarNon Executive Director
Dr. Nirmal Kumar GangulyNon Executive Director
Mrs. Shalini Kanwar ChandNon Executive Director
Dr. Sanjaya BaruIndependent Director
Ms. Deepa Gopalan WadhwaIndependent Director
Mr. Sunil TandonIndependent Director
Mr. Sanjib SenIndependent Director
Dr. Subbaraman NarayanIndependent Director

FAQ

What is the latest intrinsic value of Artemis Medicare Services Ltd?

The latest intrinsic value of Artemis Medicare Services Ltd as on 18 December 2024 is ₹459.38, which is 40.48% higher than the current market price of ₹327.00. The stock has a market capitalization of 4,511 Cr. and recorded a high/low of ₹348/141 during the current fiscal year 2024-2025. As of Sep 2024, the company has reserves of ₹783 Cr and total liabilities of ₹1,318 Cr.

What is the Market Cap of Artemis Medicare Services Ltd?

The Market Cap of Artemis Medicare Services Ltd is 4,511 Cr..

What is the current Stock Price of Artemis Medicare Services Ltd as on 18 December 2024?

The current stock price of Artemis Medicare Services Ltd as on 18 December 2024 is 327.

What is the High / Low of Artemis Medicare Services Ltd stocks in FY 2024-2025?

In FY 2024-2025, the High / Low of Artemis Medicare Services Ltd stocks is 348/141.

What is the Stock P/E of Artemis Medicare Services Ltd?

The Stock P/E of Artemis Medicare Services Ltd is 69.5.

What is the Book Value of Artemis Medicare Services Ltd?

The Book Value of Artemis Medicare Services Ltd is 57.9.

What is the Dividend Yield of Artemis Medicare Services Ltd?

The Dividend Yield of Artemis Medicare Services Ltd is 0.14 %.

What is the ROCE of Artemis Medicare Services Ltd?

The ROCE of Artemis Medicare Services Ltd is 13.6 %.

What is the ROE of Artemis Medicare Services Ltd?

The ROE of Artemis Medicare Services Ltd is 11.4 %.

What is the Face Value of Artemis Medicare Services Ltd?

The Face Value of Artemis Medicare Services Ltd is 1.00.

About the Author

Author Avatar
Getaka

Getaka, CFA, a financial analyst with 15 years of experience in the industry. Getaka holds an MBA degree and the Chartered Financial Analyst designation, demonstrating his profound understanding of financial analysis and investment management. Throughout his career, he has conducted numerous financial analyses and due diligence processes for companies in the industry, and has a strong track record of identifying key trends and opportunities. He leverages his expertise to deliver a thorough financial analysis of a company, encompassing its financial performance, key ratios, future prospects, and risks. Getaka is committed to providing accurate, reliable, and trustworthy information to help readers make informed decisions about their finances and investments.

Disclaimer: This article is for informational purposes only and should not be construed as financial advice. The author is not a SEBI registered financial advisor and does not have any vested interest in Artemis Medicare Services Ltd. Investors are advised to conduct their own due diligence and consult with a financial professional before making any investment decisions. The information provided in this article is based on publicly available data and the author's analysis, but it may not be comprehensive or up-to-date. The author and getaka.co.in are not responsible for any errors or omissions in the content. This article is not intended to promote any particular investment strategy or recommendation, and readers should consult with their own financial advisors before making any investment decisions. Data Source: NSE